These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 26964641

  • 21. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R, Aoki Y, Takeda S, Yokota T.
    Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.
    Lu-Nguyen NB, Jarmin SA, Saleh AF, Popplewell L, Gait MJ, Dickson G.
    Mol Ther; 2015 Aug; 23(8):1341-1348. PubMed ID: 25959011
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.
    Chen S, Le BT, Chakravarthy M, Kosbar TR, Veedu RN.
    Sci Rep; 2019 Apr 15; 9(1):6078. PubMed ID: 30988454
    [Abstract] [Full Text] [Related]

  • 29. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
    Wang M, Wu B, Tucker JD, Lu P, Lu Q.
    Int J Nanomedicine; 2015 Apr 15; 10():5635-46. PubMed ID: 26366082
    [Abstract] [Full Text] [Related]

  • 30. Long-Term Morpholino Oligomers in Hexose Elicits Long-Lasting Therapeutic Improvements in mdx Mice.
    Han G, Lin C, Ning H, Gao X, Yin H.
    Mol Ther Nucleic Acids; 2018 Sep 07; 12():478-489. PubMed ID: 30195785
    [Abstract] [Full Text] [Related]

  • 31. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G.
    J Gene Med; 2004 Oct 07; 6(10):1149-58. PubMed ID: 15386737
    [Abstract] [Full Text] [Related]

  • 32. Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.
    Sharp PS, Bye-a-Jee H, Wells DJ.
    Mol Ther; 2011 Jan 07; 19(1):165-71. PubMed ID: 20924363
    [Abstract] [Full Text] [Related]

  • 33. Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
    Blain AM, Greally E, McClorey G, Manzano R, Betts CA, Godfrey C, O'Donovan L, Coursindel T, Gait MJ, Wood MJ, MacGowan GA, Straub VW.
    PLoS One; 2018 Jan 07; 13(6):e0198897. PubMed ID: 29912990
    [Abstract] [Full Text] [Related]

  • 34. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
    Hiyoshi T, Zhao F, Baba R, Hirakawa T, Kuboki R, Suzuki K, Tomimatsu Y, O'Donnell P, Han S, Zach N, Nakashima M.
    Skelet Muscle; 2023 Nov 18; 13(1):19. PubMed ID: 37980539
    [Abstract] [Full Text] [Related]

  • 35. Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse.
    Fletcher S, Honeyman K, Fall AM, Harding PL, Johnsen RD, Steinhaus JP, Moulton HM, Iversen PL, Wilton SD.
    Mol Ther; 2007 Sep 18; 15(9):1587-92. PubMed ID: 17579573
    [Abstract] [Full Text] [Related]

  • 36. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH, Sirsi SR, Latta DR, Lutz GJ.
    Mol Ther; 2006 Jul 18; 14(1):88-96. PubMed ID: 16488666
    [Abstract] [Full Text] [Related]

  • 37. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O.
    Science; 2004 Dec 03; 306(5702):1796-9. PubMed ID: 15528407
    [Abstract] [Full Text] [Related]

  • 38. Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model.
    Hasegawa J, Nagata T, Ihara K, Tanihata J, Ebihara S, Yoshida-Tanaka K, Yanagidaira M, Ohara M, Sasaki A, Nakayama M, Yamamoto S, Ishii T, Iwata-Hara R, Naito M, Miyata K, Sakaue F, Yokota T.
    Nat Commun; 2024 Sep 26; 15(1):7530. PubMed ID: 39327422
    [Abstract] [Full Text] [Related]

  • 39. Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
    Yang L, Niu H, Gao X, Wang Q, Han G, Cao L, Cai C, Weiler J, Yin H.
    PLoS One; 2013 Sep 26; 8(4):e61584. PubMed ID: 23658612
    [Abstract] [Full Text] [Related]

  • 40. Induced dystrophin exon skipping in human muscle explants.
    McClorey G, Fall AM, Moulton HM, Iversen PL, Rasko JE, Ryan M, Fletcher S, Wilton SD.
    Neuromuscul Disord; 2006 Oct 26; 16(9-10):583-90. PubMed ID: 16919955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.